Related Experiment Video
Updated: Dec 11, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Understanding COVID-19: From Origin to Potential Therapeutics
Muhammad Moazzam1, Muhammad Imran Sajid1,2, Hamza Shahid1
1Faculty of Pharmacy, University of Central Punjab, Lahore 54700, Pakistan.
This review details the origins, evolution, and pathogenesis of Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2. It also covers clinical features and the current status of COVID-19 treatments and vaccine trials.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- The Coronavirus Disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, poses a significant global health threat.
- Initial cases were linked to the Huanan seafood market in China, with potential animal reservoirs including bats, pangolins, and snakes.
- COVID-19 presents with severe respiratory symptoms, and immunocompromised individuals are at higher risk of mortality.
Purpose of the Study:
- To provide a comprehensive overview of COVID-19, consolidating current information on its origins, evolution, and pathogenesis.
- To detail the clinical manifestations and current treatment landscape for COVID-19.
- To present an account of ongoing clinical trials for vaccines and therapeutics.
Main Methods:
- Literature review and synthesis of published research articles and reports on COVID-19.
- Compilation of epidemiological data and pathogenic mechanisms.
- Analysis of clinical features and therapeutic strategies, including ongoing clinical trials.
Main Results:
- The review consolidates information on the origins and evolution of SARS-CoV-2.
- Detailed descriptions of COVID-19's clinical features, pathogenesis, and epidemiology are provided.
- Current treatment options and the status of vaccine and therapeutic clinical trials are outlined.
Conclusions:
- Accurate and reliable information on COVID-19 is crucial during the ongoing pandemic.
- This review serves as an up-to-date resource on COVID-19's multifaceted aspects.
- Understanding the disease's progression and ongoing research is vital for effective management.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Drug Discovery: Overview
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Single Nucleotide Polymorphisms-SNPs
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

